Search
Search
About
Log in
Join
Experiences with
Carcinoma
Posts
Communities
1,176 public posts
Filter results
Technology is coming
Researchers used AlphaFold and the drug discovery[/i] [i]
platform Pharma.AI to design and synthesize a potential drug to treat hepatocellular
(HCC), the most common type of primary liver cancer.[/i]
Researchers used AlphaFold and the drug discovery[/i] [i]
platform Pharma.AI to design and synthesize a potential drug to treat hepatocellular
(HCC), the most common type of primary liver cancer.[/i]
Scout4answers
in
Advanced Prostate Cancer
1 year ago
Difficult decision before a robot assisted laparoscopic prostatectomy planned for March
MRI and biopsy diagnosed prostate
carcinoma
left lobe.
MRI and biopsy diagnosed prostate
carcinoma
left lobe.
Hockeyforever
in
Prostate Cancer Network
1 year ago
Shocked and confused about gallbladder result
received a phone call from the gastro yesterday telling me that the radiologist made an addendum to my ultrasound results after the gastro had talked to him and that they had found a 2cm (really large) unidentified soft tissue something in my liver and although it's not extremely likely to be a mass/
carcinoma
received a phone call from the gastro yesterday telling me that the radiologist made an addendum to my ultrasound results after the gastro had talked to him and that they had found a 2cm (really large) unidentified soft tissue something in my liver and although it's not extremely likely to be a mass/
carcinoma
SerenityFirefly
in
British Liver Trust
10 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Genistein potentiates the radiation effect on prostate carcinoma cells
These studies suggest a potential of combining genistein with radiation for the treatment of localized prostate
carcinoma
." I took the product during radiation. The radiologist couldn't care less. As it happened, I could never handle 4 doses in a day. I fell back to 1.
These studies suggest a potential of combining genistein with radiation for the treatment of localized prostate
carcinoma
." I took the product during radiation. The radiologist couldn't care less. As it happened, I could never handle 4 doses in a day. I fell back to 1.
pjoshea13
in
Fight Prostate Cancer
1 year ago
ribs removed
Hi all, so my partners three weeks after his lobectomy and recovering well As his tumor was breaking into his ribs he had to get four ribs removed also, it was squamous
carcinoma
nsc.
Hi all, so my partners three weeks after his lobectomy and recovering well As his tumor was breaking into his ribs he had to get four ribs removed also, it was squamous
carcinoma
nsc.
Clareoh
in
The Roy Castle Lung Cancer Foundation
1 year ago
Decided to have a robot assisted laparoscopic radical prostatectomy - update
Histology report: Peripheral zone
carcinoma
— Gleason Grade 4+3=7, Grade 4 = 70%. No longer prostate confined. Specimen confined and did not extend to circumferential margins. Continence recovery: have achieved dryness at night. Doing pelvic floor muscle endurance training every day.
Histology report: Peripheral zone
carcinoma
— Gleason Grade 4+3=7, Grade 4 = 70%. No longer prostate confined. Specimen confined and did not extend to circumferential margins. Continence recovery: have achieved dryness at night. Doing pelvic floor muscle endurance training every day.
Hockeyforever
in
Prostate Cancer Network
1 year ago
Patient survey on treatment after chemotherapy
If you are over 18, are being treated in the UK and have been diagnosed with advanced high grade serous ovarian cancer, high grade epithelial ovarian, fallopian tube or primary peritoneal
carcinoma
then we'd really appreciate it if you are able to take 5 minutes to share your experiences.
If you are over 18, are being treated in the UK and have been diagnosed with advanced high grade serous ovarian cancer, high grade epithelial ovarian, fallopian tube or primary peritoneal
carcinoma
then we'd really appreciate it if you are able to take 5 minutes to share your experiences.
TheOvacomeTeam
Partner
in
My Ovacome
1 year ago
Brain metastasis
"PC3 is characteristic of small cell neoendocrine
carcinoma
". Most PCa bone mets are osteoblastic, but PC-3 is osteolytic. [2ii] iii) DU145: androgen-sensitive. Does not express PSA. Moderate metastatic potential. [2iii] Anyway, back to the new paper.
"PC3 is characteristic of small cell neoendocrine
carcinoma
". Most PCa bone mets are osteoblastic, but PC-3 is osteolytic. [2ii] iii) DU145: androgen-sensitive. Does not express PSA. Moderate metastatic potential. [2iii] Anyway, back to the new paper.
pca2004
in
Fight Prostate Cancer
11 months ago
Treatments
Does anyone know a website that posts the latest treatments/breakthroughs for Hepatocellular
Carcinoma
?
Does anyone know a website that posts the latest treatments/breakthroughs for Hepatocellular
Carcinoma
?
RolloMay
Patient
in
Blue Faery Liver Cancer
2 years ago
Recurrence!
Bronch 6/23
DIAGNOSIS(ES): Lung, RUL, navigational cryobiopsy: Lung parenchyma with focally minimal fibrosis, no explanation for a nodule is seen, no granulomata or
seen. Awaiting 6 additional levels.
Bronch 6/23
DIAGNOSIS(ES): Lung, RUL, navigational cryobiopsy: Lung parenchyma with focally minimal fibrosis, no explanation for a nodule is seen, no granulomata or
seen. Awaiting 6 additional levels.
kri312
in
The Roy Castle Lung Cancer Foundation
9 months ago
Does having CLL really make you 3 times more likely to get (another) cancer, and does CLL treatment add to the risk? - Part 1
• Other SPM risks of note are colon, lung and kidney cancer, and soft tissue
carcinoma
, all with SIRs in the range 1 to 3. • For several of the SPMs listed the absolute excess risk (AER) is modest to negligible, e.g. myeloid blood cancer, breast, ovarian and endometrial cancers.
• Other SPM risks of note are colon, lung and kidney cancer, and soft tissue
carcinoma
, all with SIRs in the range 1 to 3. • For several of the SPMs listed the absolute excess risk (AER) is modest to negligible, e.g. myeloid blood cancer, breast, ovarian and endometrial cancers.
bennevisplace
in
CLL Support
4 months ago
Heterogeneity and genomic evolution of metastatic prostate cancer, bioRxiv Preprint, Posted September 04, 2023.
This score can also identify metastasis-featured primary tumors for breast cancer, bladder cancer, liver cancer, and uterine corpus endometrial
carcinoma
.[/i] [i]
Conclusion
[/i][i] Our research proposes 14 molecular features potentially driving prostate cancer metastasis.
This score can also identify metastasis-featured primary tumors for breast cancer, bladder cancer, liver cancer, and uterine corpus endometrial
carcinoma
.[/i] [i]
Conclusion
[/i][i] Our research proposes 14 molecular features potentially driving prostate cancer metastasis.
CaptnMojoe
in
Fight Prostate Cancer
9 months ago
Not doing good at all
I've been reading about the small cell
carcinoma
lung cancer that I was diagnosed with and in spite of the positive things people have said about it, that it's treatable, I'm having a very difficult time dealing with this.
I've been reading about the small cell
carcinoma
lung cancer that I was diagnosed with and in spite of the positive things people have said about it, that it's treatable, I'm having a very difficult time dealing with this.
blueslite
in
Anxiety and Depression Support
1 year ago
rise in ca125
hi I had surgery 4 years ago to remove everything including my cervix, 2 years ago I started bleeding which turned out to be 2 Lgc in surgery the found another tumour on my uretha which the had to cut part of this way, after which I had chemo
carcinoma
and taxol.
hi I had surgery 4 years ago to remove everything including my cervix, 2 years ago I started bleeding which turned out to be 2 Lgc in surgery the found another tumour on my uretha which the had to cut part of this way, after which I had chemo
carcinoma
and taxol.
Heidi1965
in
My Ovacome
1 year ago
Sadly, I've joined the PCa club ...
Prostate tissue with small focus of atypical glands, highly suspicious for low-grade
carcinoma
. See note. NOTE: Although these findings are highly atypical and suspicious for adenocarcinoma, there is insufficient cytologic and/or architectural atypia to establish a definitive diagnosis.
Prostate tissue with small focus of atypical glands, highly suspicious for low-grade
carcinoma
. See note. NOTE: Although these findings are highly atypical and suspicious for adenocarcinoma, there is insufficient cytologic and/or architectural atypia to establish a definitive diagnosis.
nvidia-ati
in
Prostate Cancer Network
1 year ago
lost in translation...
performed before L-T4 intake or at least 4 h after L-T4 intake (18), but other international guidelines do not yet (19) To the best of our knowledge, only Conte et al. (20) investigated if timing of blood sampling affected the evaluation of (morning) L-T4 treatment in patients with differentiated thyroid
carcinoma
performed before L-T4 intake or at least 4 h after L-T4 intake (18), but other international guidelines do not yet (19) To the best of our knowledge, only Conte et al. (20) investigated if timing of blood sampling affected the evaluation of (morning) L-T4 treatment in patients with differentiated thyroid
carcinoma
tattybogle
in
Thyroid UK
1 month ago
After RP who goes over Pathology?
REGIONAL LYMPH NODES: Number of Lymph Nodes Involved: 0 Number of lymph nodes examined: 8 VI.MARGINS: Involved by invasive
carcinoma
; non-limited (=3 mm) Location of positive margin: Bladder neckVII. TUMOR QUANTITATION: Low volume (<5%)VIII. SEMINAL VESICLE INVASION: Cannot be assessedIX.
REGIONAL LYMPH NODES: Number of Lymph Nodes Involved: 0 Number of lymph nodes examined: 8 VI.MARGINS: Involved by invasive
carcinoma
; non-limited (=3 mm) Location of positive margin: Bladder neckVII. TUMOR QUANTITATION: Low volume (<5%)VIII. SEMINAL VESICLE INVASION: Cannot be assessedIX.
Shorehousejam
in
Advanced Prostate Cancer
1 year ago
The emerging role of fatty acid binding protein 5 (FABP5) in cancers
The evidence base is currently strongest for liver, prostate, breast, and brain cancers, and squamous cell
carcinoma
(SCC), which could represent relevant patient populations for any drug discovery programme.
The evidence base is currently strongest for liver, prostate, breast, and brain cancers, and squamous cell
carcinoma
(SCC), which could represent relevant patient populations for any drug discovery programme.
pca2004
in
Fight Prostate Cancer
1 year ago
Please Help Explain Results Please help explain Pathology report after Davinci Radical Prostatectomy w/ Extended Lymph Node Dissection
Eight lymph nodes are negative for metastatic
carcinoma
(0/8). One lymph node shows changes consistent with treatment effect (i.e. tumor regression); no viable tumor is identified.
Eight lymph nodes are negative for metastatic
carcinoma
(0/8). One lymph node shows changes consistent with treatment effect (i.e. tumor regression); no viable tumor is identified.
Shorehousejam
in
Advanced Prostate Cancer
1 year ago
Thromboxane & Aspirin
"Ten consecutive male patients with prostatic
carcinoma
participating in a randomized study comparing the effects of parenteral oestrogen therapy (n = 5) with orchidectomy (n = 5) were included. Oestrogen was given as polyestradiol phosphate 240 mg i.m. every month ..."
"Ten consecutive male patients with prostatic
carcinoma
participating in a randomized study comparing the effects of parenteral oestrogen therapy (n = 5) with orchidectomy (n = 5) were included. Oestrogen was given as polyestradiol phosphate 240 mg i.m. every month ..."
pca2004
in
Fight Prostate Cancer
1 year ago
1
...
8
9
10
...
59
Next page
10
20
30
40
50
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
225 results
My Ovacome
126 results
Thyroid UK
107 results
View top 10 communities
Sort by
Most Relevant
Newest